Q4 2025 Holdings
Filed 2026-02-17 | 45 holdings | $456.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $96.4M | 10,876,219 | 21.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $31.9M | 400,000 | 7.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $31.8M | 1,136,000 | 7.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $25.6M | 329,100 | 5.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $22.4M | 225,000 | 4.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $16.9M | 125,000 | 3.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $15.2M | 200,000 | 3.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $15.2M | 375,000 | 3.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $14.8M | 170,000 | 3.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $13.7M | 46,457 | 3.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $11.7M | 500,000 | 2.6% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $11.7M | 53,000 | 2.6% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $11.3M | 4,799,875 | 2.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $9.7M | 800,000 | 2.1% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $9.4M | 416,150 | 2.1% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $9.4M | 325,000 | 2.1% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $8.0M | 598,500 | 1.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.0M | 225,000 | 1.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $7.3M | 750,000 | 1.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.9M | 290,000 | 1.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.4M | 100,000 | 1.4% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $5.8M | 715,000 | 1.3% |
| Precigen Inc(PGEN) | COM | 74017N105 | $5.7M | 1,375,000 | 1.3% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $5.6M | 494,000 | 1.2% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $5.4M | 453,686 | 1.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $5.3M | 70,000 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $5.2M | 75,000 | 1.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $5.0M | 275,000 | 1.1% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $4.2M | 2,420,122 | 0.9% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $4.1M | 150,000 | 0.9% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $3.8M | 625,000 | 0.8% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $3.7M | 1,500,000 | 0.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.6M | 275,000 | 0.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.2M | 150,000 | 0.7% |
| Pepgen Inc(PEPG) | COM | 713317105 | $2.4M | 373,892 | 0.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.9M | 100,000 | 0.4% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $1.9M | 252,536 | 0.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $1.7M | 300,000 | 0.4% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $1.6M | 70,000 | 0.3% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $1.3M | 666,666 | 0.3% |
| Clene Inc(CLNN) | COM NEW | 185634201 | $1.2M | 199,737 | 0.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $329.5K | 20,400 | 0.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $262.0K | 50,000 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $88.0K | 266,666 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $1.3K | 66,666 | 0.0% |